“…FOXA1/2 may program both pancreatic beta cells and ventral midbrain NPCs and use the same molecular tools (e.g., K-ATP subunit genes) in different tissue types to achieve different ends (presumably insulin secretion and regulation of calcium transients, respectively). Finally, Foxa2 is regulated by insulin itself (Wolfrum et al, 2003) and several single nucleotide polymorphisms (SNPs) in the gene are significantly associated with different metabolic indicators, such as fasting blood glucose levels [e.g., rs6048205 (Manning et al, 2012;Wojcik et al, 2019;Sinnott-Armstrong et al, 2021), rs3833331 (Chen et al, 2021;Sakaue et al, 2021), rs1209523 (Xing et al, 2010;Wojcik et al, 2019), rs72470563 (Chung et al, 2021), rs1337918 (Chen et al, 2021)].…”